# Treatment of Pulmonary Sarcoidosis With Pentoxifylline

> **NCT00001877** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 100 (—)

## Conditions studied

- Pulmonary Sarcoidosis

## Interventions

- **DRUG:** Pentoxifylline

## Key facts

- **NCT ID:** NCT00001877
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-02
- **Primary completion:** —
- **Final completion:** 2004-05
- **Target enrollment:** 100 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001877, "Treatment of Pulmonary Sarcoidosis With Pentoxifylline". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00001877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*